Güler Silov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Güler Silov has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Zeynep Erdoğan
University of Health Sciences, Kayseri Training and Research Hospital, Clinic of Nuclear Medicine, Kayseri, Turkey
8 shared publicationsAyşegül Özdal
University of Health Sciences, Kayseri Training and Research Hospital, Clinic of Nuclear Medicine, Kayseri, Turkey
4 shared publications- Banu Kırtıloğlu
Samsun Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği, Samsun
4 shared publications - Fatih Bati
Department of Nuclear Medicine, Faculty of Medicine, Samsun University, Samsun, Türkiye
4 shared publications - Nilüfer Bıçakcı
Department of Nuclear Medicine, Samsun Education and Research Hospital, Samsun, Türkiye
4 shared publications - Aslı Ayan
Gülhane Education and Research Hospital
2 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 34 (3) , 234-238
Analysis of Imaging Findings in a Patient with Squamous Cell Carcinoma of the External Auditory Canal Metastatic to the Dura with Trigeminal Nerve Involvement
Analysis of Imaging Findings in a Patient with Squamous Cell Carcinoma of the External Auditory Canal Metastatic to the Dura with Trigeminal Nerve Involvement - Molecular Imaging and Radionuclide Therapy
- 1 August 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 34 (3) , 234-238
Open AccessAnalysis of Imaging Findings in a Patient with Squamous Cell Carcinoma of the External Auditory Canal Metastatic to the Dura with Trigeminal Nerve Involvement
Analysis of Imaging Findings in a Patient with Squamous Cell Carcinoma of the External Auditory Canal Metastatic to the Dura with Trigeminal Nerve Involvement - Molecular Imaging and Radionuclide Therapy
- Open Access
- 11 July 2025
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 41 (3) , 313-320
Incidental identification of elastofibroma dorsi in oncologic PET/CT imaging: a retrospective single-center analysis
Incidental identification of elastofibroma dorsi in oncologic PET/CT imaging: a retrospective single-center analysis - Turkish Journal of Surgery
- 11 July 2025
- Published by Galenos Yayinevi in Turkish Journal of Surgery
- Vol. 41 (3) , 313-320
Open AccessIncidental identification of elastofibroma dorsi in oncologic PET/CT imaging: a retrospective single-center analysis
Incidental identification of elastofibroma dorsi in oncologic PET/CT imaging: a retrospective single-center analysis - Turkish Journal of Surgery
- 10 April 2025
- Published by MediHealth Academy in Surgery on Children
- Vol. 2 (2) , 79-81
Evaluation of Yolk sac tumor in a pediatric patient with F-18 FDG PET/CT
Yolk sac tumors (YST) are malignant germ cell tumors that secrete alpha-fetoprotein (AFP). These tumors commonly occur in infants, young children, and young women and often arise from the gonads. We describe the management of YST and follow-up F-18 FDG PET/CT findings in a girl.
- 10 April 2025
- Published by MediHealth Academy in Surgery on Children
- Vol. 2 (2) , 79-81
Evaluation of Yolk sac tumor in a pediatric patient with F-18 FDG PET/CT
Yolk sac tumors (YST) are malignant germ cell tumors that secrete alpha-fetoprotein (AFP). These tumors commonly occur in infants, young children, and young women and often arise from the gonads. We describe the management of YST and follow-up F-18 FDG PET/CT findings in a girl.
- 20 January 2025
- Published by MediHealth Academy in Surgery on Children
- Vol. 2 (1) , 21-27
Nuclear medicine approaches in the field of oncologic pediatric surgery and review the risk factors for pediatric thyroid nodules
Imaging methods used in nuclear medicine are non-invasive and can be applied to all pediatric age groups, including the neonatal period. F-18 FDG-PET/CT is used for staging, evaluation of treatment response, detection of metastases, and follow-up of various pediatric malignancies. In addition, the incidence of thyroid cancer in childhood has recently increased. In this review, we examined the F-18 FDG PET/CT imaging method that guide the management of the most common malignancies in children. We also discuss in detail the risk factors used in the diagnosis of thyroid cancer frequently encountered by pediatric surgeons.
- 20 January 2025
- Published by MediHealth Academy in Surgery on Children
- Vol. 2 (1) , 21-27
Nuclear medicine approaches in the field of oncologic pediatric surgery and review the risk factors for pediatric thyroid nodules
Imaging methods used in nuclear medicine are non-invasive and can be applied to all pediatric age groups, including the neonatal period. F-18 FDG-PET/CT is used for staging, evaluation of treatment response, detection of metastases, and follow-up of various pediatric malignancies. In addition, the incidence of thyroid cancer in childhood has recently increased. In this review, we examined the F-18 FDG PET/CT imaging method that guide the management of the most common malignancies in children. We also discuss in detail the risk factors used in the diagnosis of thyroid cancer frequently encountered by pediatric surgeons.
- Open Access
- 30 September 2024
- Published by MediHealth Academy in Surgery on Children
- Vol. 1 (3) , 63-70
The role of nuclear medicine techniques; Tc-99m-labeled dimercaptosuccinic acid, diethylenetriaminepentaacetic acid, and mercaptoacetyltriglycine scintigraphies in pediatric surgery
The purpose of this review is to highlight the pivotal role of nuclear medicine in pediatric surgery, specifically in the diagnosis and management of nephro-urological conditions. This review focuses on the applications and advantages of three key nuclear medicine techniques: Tc-99m dimercaptosuccinic acid (DMSA), Tc-99m diethylenetriaminepentaacetic acid (DTPA), and Tc-99m mercaptoacetyltriglycine (MAG3) scintigraphies. These imaging modalities are crucial for providing detailed anatomical and functional information with minimal invasiveness, essential for evaluating congenital anomalies, urinary tract infections, and obstructive uropathies in children. DMSA Scintigraphy is established as the gold standard for detecting renal cortical scarring and assessing functional renal parenchymal damage. It offers superior sensitivity and specificity compared to other imaging techniques, making it indispensable for identifying renal scars from recurrent urinary tract infections or pyelonephritis. DTPA Scintigraphy is critical for measuring glomerular filtration rate (GFR) and analyzing renogram curves, providing quantitative assessments of renal function. It effectively evaluates renal perfusion and identifies perfusion defects and renal ischemia, essential for managing conditions like renal artery stenosis and unilateral kidney disease. MAG3 Scintigraphy excels in dynamic renal scintigraphy, particularly in patients with impaired renal function. It provides high-quality images and superior diagnostic capability, making it invaluable for assessing ureteropelvic junction obstruction and other obstructive uropathies in pediatric patients. The review concludes by emphasizing the integration of these scintigraphy techniques with SPECT/CT, enhancing diagnostic accuracy and providing comprehensive anatomical and functional insights. Despite concerns regarding radiation exposure, measures such as dose optimization and advanced imaging techniques ensure safety and efficacy in pediatric applications.
- 30 September 2024
- Published by MediHealth Academy in Surgery on Children
- Vol. 1 (3) , 63-70
Open AccessThe role of nuclear medicine techniques; Tc-99m-labeled dimercaptosuccinic acid, diethylenetriaminepentaacetic acid, and mercaptoacetyltriglycine scintigraphies in pediatric surgery
The purpose of this review is to highlight the pivotal role of nuclear medicine in pediatric surgery, specifically in the diagnosis and management of nephro-urological conditions. This review focuses on the applications and advantages of three key nuclear medicine techniques: Tc-99m dimercaptosuccinic acid (DMSA), Tc-99m diethylenetriaminepentaacetic acid (DTPA), and Tc-99m mercaptoacetyltriglycine (MAG3) scintigraphies. These imaging modalities are crucial for providing detailed anatomical and functional information with minimal invasiveness, essential for evaluating congenital anomalies, urinary tract infections, and obstructive uropathies in children. DMSA Scintigraphy is established as the gold standard for detecting renal cortical scarring and assessing functional renal parenchymal damage. It offers superior sensitivity and specificity compared to other imaging techniques, making it indispensable for identifying renal scars from recurrent urinary tract infections or pyelonephritis. DTPA Scintigraphy is critical for measuring glomerular filtration rate (GFR) and analyzing renogram curves, providing quantitative assessments of renal function. It effectively evaluates renal perfusion and identifies perfusion defects and renal ischemia, essential for managing conditions like renal artery stenosis and unilateral kidney disease. MAG3 Scintigraphy excels in dynamic renal scintigraphy, particularly in patients with impaired renal function. It provides high-quality images and superior diagnostic capability, making it invaluable for assessing ureteropelvic junction obstruction and other obstructive uropathies in pediatric patients. The review concludes by emphasizing the integration of these scintigraphy techniques with SPECT/CT, enhancing diagnostic accuracy and providing comprehensive anatomical and functional insights. Despite concerns regarding radiation exposure, measures such as dose optimization and advanced imaging techniques ensure safety and efficacy in pediatric applications.
- Open Access
- 1 November 2023
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 33 (11) , 1229-1234
Pulmonary Artery Diameter Measurement and Semiquantitative Visual Scoring with Q-SPECT-CT in Acute Pulmonary Embolism
To investigate whether pulmonary artery diameters obtained from lung perfusion single-photon emission computed tomography-computed tomography (SPECT-CT) images and semiquantitative visual scoring (SVS) could serve as predictors of chronic pulmonary thromboembolic disease (CPTED) in acute pulmonary embolism patients (APE). Observational study. Place and Duration of the Study: Department of Nuclear Medicine, Samsun Provincial Health Directorate, Gazi State Hospital, Samsun, Turkey, from January 2016 to March 2021. A total of 142 patients undergoing lung perfusion SPECT-CT were included in this study. Patients were classified as APE (+) (n=42) and APE (-) (n=100) based on laboratory and radiological findings, clinical diagnosis, and treatment protocol. Non-contrast CT images were used to determine the diameters (mm) of the main (MPA), right (RPA), and left (LPA) pulmonary arteries and the main pulmonary artery/aorta (PA/AO) ratio. All perfusion defects were scored using SVS for the PE (+) group. Seventeen patients with a diagnosis of CPTED were followed up. The scores and arterial diameters of recovered APE and follow-up patients were compared. The mean diameters (mm) of MPA, RPA, and LPA and PA/AO ratio were 29.74±5.51, 21.73±4.11, 22.74±4.16, and 0.83±0.16 in the APE (+) group and 26.18±4.99, 19.35±3.84, 19.49±4.15, and 0.77±0.15 in the APE (-) group, respectively (p<0.001). Mean MPA diameter (mm), total defect (TD), right visual defect (RVD), and PA/AO ratio were 31.67±15.65, 29.88±15.59, 17.65±10.51, and 0.91±0.18 in the CPTED group and 28.06±4.59, 18.92±13.30, 10.4±7.41, and 0.78±0.15 in the recovered APE group, respectively (p<0.05). Assessment of pulmonary artery diameter and PA/AO ratio may indicate APE, but TD and RVD scores may be predictive factors for CPTED when included in the assessment along with MPA dilatation and PA/AO ratio. Acute pulmonary embolism, Pulmonary artery diameter, Lung SPECT-CT, Chronic pulmonary thromboembolic disease, Semi-quantitative visual scoring.
- 1 November 2023
- Published by College of Physicians and Surgeons Pakistan in Journal of the College of Physicians and Surgeons Pakistan
- Vol. 33 (11) , 1229-1234
Open AccessPulmonary Artery Diameter Measurement and Semiquantitative Visual Scoring with Q-SPECT-CT in Acute Pulmonary Embolism
To investigate whether pulmonary artery diameters obtained from lung perfusion single-photon emission computed tomography-computed tomography (SPECT-CT) images and semiquantitative visual scoring (SVS) could serve as predictors of chronic pulmonary thromboembolic disease (CPTED) in acute pulmonary embolism patients (APE). Observational study. Place and Duration of the Study: Department of Nuclear Medicine, Samsun Provincial Health Directorate, Gazi State Hospital, Samsun, Turkey, from January 2016 to March 2021. A total of 142 patients undergoing lung perfusion SPECT-CT were included in this study. Patients were classified as APE (+) (n=42) and APE (-) (n=100) based on laboratory and radiological findings, clinical diagnosis, and treatment protocol. Non-contrast CT images were used to determine the diameters (mm) of the main (MPA), right (RPA), and left (LPA) pulmonary arteries and the main pulmonary artery/aorta (PA/AO) ratio. All perfusion defects were scored using SVS for the PE (+) group. Seventeen patients with a diagnosis of CPTED were followed up. The scores and arterial diameters of recovered APE and follow-up patients were compared. The mean diameters (mm) of MPA, RPA, and LPA and PA/AO ratio were 29.74±5.51, 21.73±4.11, 22.74±4.16, and 0.83±0.16 in the APE (+) group and 26.18±4.99, 19.35±3.84, 19.49±4.15, and 0.77±0.15 in the APE (-) group, respectively (p<0.001). Mean MPA diameter (mm), total defect (TD), right visual defect (RVD), and PA/AO ratio were 31.67±15.65, 29.88±15.59, 17.65±10.51, and 0.91±0.18 in the CPTED group and 28.06±4.59, 18.92±13.30, 10.4±7.41, and 0.78±0.15 in the recovered APE group, respectively (p<0.05). Assessment of pulmonary artery diameter and PA/AO ratio may indicate APE, but TD and RVD scores may be predictive factors for CPTED when included in the assessment along with MPA dilatation and PA/AO ratio. Acute pulmonary embolism, Pulmonary artery diameter, Lung SPECT-CT, Chronic pulmonary thromboembolic disease, Semi-quantitative visual scoring.
- Open Access
- 11 October 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (20) , 3182
The Relationship between Planar and SPECT/CT Parameters and Functional Markers in Primary Hyperparathyroidism
This study aimed to investigate the relationship between quantitative and volumetric parameters of technetium-99-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) imaging and hormonal and biochemical markers in primary hyperparathyroidism (PHPT) patients with single adenoma. In this retrospective study, 70 patients with a single adenoma who underwent 99mTc-MIBI imaging for the diagnosis of PHPT were examined. Early and delayed MIBI lesion/background ratios (eLBR and dLBR), early and delayed lesion/thyroid ratio (eLTR and dLTR), and retention index (RI) were calculated as planar dual-phase scintigraphy parameters. Adenoma volume (Svol) and parathormone (PTH)/Svol ratio were measured as SPECT/CT-derived parameters. Calcium levels exhibited a positive correlation with eLBR (r = 0.33, p < 0.001), dLBR (r = 0.29, p = 0.01), dLTR (r = 0.31, p < 0.001), and PTH/Svol (r = 0.38, p < 0.001). PTH did not correlate with planar parameters and Svol. Among the imaging parameters, only the PTH/Svol ratio showed a negative correlation with phosphorus levels (r = −0.29, p = 0.02). For predicting disease severity, the PTH/Svol ratio exhibited similar diagnostic performance to PTH and phosphorus levels but outperformed the eLBR and dLBR. Both planar and SPECT-derived parameters can provide valuable insights into the functional status of the parathyroid adenoma and the associated disease severity. PTH/Svol ratio, combining imaging and laboratory findings to provide a more comprehensive approach to patient care, could be an exciting new indicator.
- 11 October 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (20) , 3182
Open AccessThe Relationship between Planar and SPECT/CT Parameters and Functional Markers in Primary Hyperparathyroidism
This study aimed to investigate the relationship between quantitative and volumetric parameters of technetium-99-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) imaging and hormonal and biochemical markers in primary hyperparathyroidism (PHPT) patients with single adenoma. In this retrospective study, 70 patients with a single adenoma who underwent 99mTc-MIBI imaging for the diagnosis of PHPT were examined. Early and delayed MIBI lesion/background ratios (eLBR and dLBR), early and delayed lesion/thyroid ratio (eLTR and dLTR), and retention index (RI) were calculated as planar dual-phase scintigraphy parameters. Adenoma volume (Svol) and parathormone (PTH)/Svol ratio were measured as SPECT/CT-derived parameters. Calcium levels exhibited a positive correlation with eLBR (r = 0.33, p < 0.001), dLBR (r = 0.29, p = 0.01), dLTR (r = 0.31, p < 0.001), and PTH/Svol (r = 0.38, p < 0.001). PTH did not correlate with planar parameters and Svol. Among the imaging parameters, only the PTH/Svol ratio showed a negative correlation with phosphorus levels (r = −0.29, p = 0.02). For predicting disease severity, the PTH/Svol ratio exhibited similar diagnostic performance to PTH and phosphorus levels but outperformed the eLBR and dLBR. Both planar and SPECT-derived parameters can provide valuable insights into the functional status of the parathyroid adenoma and the associated disease severity. PTH/Svol ratio, combining imaging and laboratory findings to provide a more comprehensive approach to patient care, could be an exciting new indicator.
- Open Access
- 1 October 2023
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 32 (3) , 214-220
A Study of CT-derived Radiation Dose Calculation in Lung Q-SPECT/CT Imaging
To investigate the amount of effective dose (ED) due to the computed tomography (CT) component of lung perfusion-single-photon emission computed tomography (Q-SPECT)/CT. In this single-center retrospective study, imaging data were collected from the clinic database for the period 2016-2022. The 327 patients identified were aged between 20 and 94 years. Tube voltage, tube current, pitch, gantry rotation time, volume CT dose index, and dose-length product (DLP) were recorded. The DLP was then converted to an ED using the conversion factors. The comparison of the ED between two groups was performed using the Mann-Whitney U non-parametric test. ED (mean ± standard deviation, mSv) was 1.20±0.70 for the pulmonary embolism (PE) (-) and 1.54±1.04 for the PE (+) cases (p<0.05). It was observed that there was a 28% increase in the ED for the PE (+) cases. In addition, each of the PE (-) and PE (+) cases was divided into two groups according to the use of the computed tomography dose reduction (CTDR): without CTDR protocol group (non-CTDR) and with CTDR protocol group (CTDR). For those groups, ED were obtained as 0.87±0.72 and 1.55±0.47 for PE (-) cases (p0.05) correspondingly. For a deeper understanding, ED was calculated for all three groups formed with different tube voltage values applied for the non-CTDR and CTDR groups.There was a 42% decrease in the ED for group 1 PE (+) compared to group 2 PE (+) (1.21±0.28, 2.07±0.91, p<0.05) and there was a 41% decrease in the ED for group 1 PE (-) compared to group 2 PE (-) cases (1.17±0.32, 1.97±0.65, p<0.05). It could be concluded that the effective DR protocol is the non-CTDR protocol for the PE (-) cases and the application of the tube voltage at the level of 100 kVp for the PE (+) cases.
- 1 October 2023
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 32 (3) , 214-220
Open AccessA Study of CT-derived Radiation Dose Calculation in Lung Q-SPECT/CT Imaging
To investigate the amount of effective dose (ED) due to the computed tomography (CT) component of lung perfusion-single-photon emission computed tomography (Q-SPECT)/CT. In this single-center retrospective study, imaging data were collected from the clinic database for the period 2016-2022. The 327 patients identified were aged between 20 and 94 years. Tube voltage, tube current, pitch, gantry rotation time, volume CT dose index, and dose-length product (DLP) were recorded. The DLP was then converted to an ED using the conversion factors. The comparison of the ED between two groups was performed using the Mann-Whitney U non-parametric test. ED (mean ± standard deviation, mSv) was 1.20±0.70 for the pulmonary embolism (PE) (-) and 1.54±1.04 for the PE (+) cases (p<0.05). It was observed that there was a 28% increase in the ED for the PE (+) cases. In addition, each of the PE (-) and PE (+) cases was divided into two groups according to the use of the computed tomography dose reduction (CTDR): without CTDR protocol group (non-CTDR) and with CTDR protocol group (CTDR). For those groups, ED were obtained as 0.87±0.72 and 1.55±0.47 for PE (-) cases (p0.05) correspondingly. For a deeper understanding, ED was calculated for all three groups formed with different tube voltage values applied for the non-CTDR and CTDR groups.There was a 42% decrease in the ED for group 1 PE (+) compared to group 2 PE (+) (1.21±0.28, 2.07±0.91, p<0.05) and there was a 41% decrease in the ED for group 1 PE (-) compared to group 2 PE (-) cases (1.17±0.32, 1.97±0.65, p<0.05). It could be concluded that the effective DR protocol is the non-CTDR protocol for the PE (-) cases and the application of the tube voltage at the level of 100 kVp for the PE (+) cases.